|
iPhone-friendly FDA News |
Drug Shortages
Sep 08
Lundbeck voluntarily recalled NeoProfen as a safety precaution. As NeoProfen stock is being replenished by the manufacturer, supply is anticipated to be available in mid-2011.
Sep 07
BMS reports the Etopophos (100mg vials) is available - NDC 00015-3404-15.
Sep 02
Bedford has all etoposide solution for injection 20 mg/mL presentations on back order and the company estimates a release date of early-September, 2010. Teva has etoposide solution for injection 20 mg/mL on back order and will be releasing product the week of September 6th. APP has all etoposide solution for injection 20 mg/mL presentations on back order and lot releases scheduled to be available early-September, 2010
Sep 02
All 3 firms report ongoing releases.
Sep 02
Hospira is continuing to produce and release the 10 mL LifeShield Abboject syringe with 1.5 inch, 21-gauge needle (NDC 00409-4921-34) and the 10 mL Abboject syringe with 3.5 inch, 18-gauge needle (NDC 00409-4901-18). Amphastar (IMS) reports availability of their Epinephrine 0.1mg/ml syringes (NDC 0548-3316-00)/product code 3316. Amphastar (IMS) in cooperation with FDA will re-introduce its emergency syringes including Dextrose 50%, Epinephrine 0.1mg/mL, Calcium Chloride 100mg/mL, Sodium Bicarbonate 8.4%, Atropine Sulfate 0.1mg/mL, Lidocaine 2%, and Morphine 1mg/mL.
Sep 02
Hospira is allocating all of their products: (10 mg/mL, 2 mL vial (NDC 0409-6102-02 ), 10 mg/mL, 4 mL vial (NDC 0409-6102-04) , 10 mg/mL, 10 mL bottle (NDC 0409-6102-10), 10 mg/mL, 4 mL Ansyr syringe (NDC 0409-9631-04) , 10mg/ml 10 ml Ansyr Syringe (NDC 0409-1639-10).
Sep 02
APP has haloperidol decanoate available in 50 mg/mL 1 mL vials (NDC 63323-0469-01), 50 mg/mL 5 mL vials (NDC 63323-0469-05), 100 mg/mL 1mL vials (NDC 63323-0471-01), and 100 mg/mL 5 mL vials (NDC 63323-0471-05).
Sep 02
Product continues to be available with short expiration dating.
Sep 02
Bedford will be releasing 350 mg (NDC 55390-0054-01), and 200 mg (NDC 55390-0053-01) in September and is working on the additional presentations as well.
Sep 02
Teva has available mexiletine 250 mg capsules (NDC 00093-8741-01). The 150 mg capsules are estimated to be released mid Sept and the 200mg do not have a release date currently.
Sep 02
Bedford plans to have the 5 mg (NDC 55390-0251-01) and 5 mg Novaplus (NDC 55390-0451-01) vials available as well as Mitomycin 20 mg (NDC 55390-0252-01) and 20 mg Novaplus (NDC 55390-0452-01) vials and 40mg and 40mg Novaplus vials available in September. Accord has mitomycin 20 mg vials (NDC 16729-0108-11) and anticipates the 5 mg vials will be available by mid-September. They have a limited supply of 5mg vials for emergency use.
Sep 02
Updates for Hospira, Baxter and Amphastar.
Sep 02
Hospira plans releases of Quelecin 100 mg/mL, 10 mL Vial (NDC 0409-6970-10) and 20mg/ml 10 mL Vial (NDC 0409-6629-02) in September.
Sep 01
Updates for the Dear Doctor and Dear Patient Letters.
Sep 01
Hospira reports that the 50% 50 mL vials (NDC 00409-6648-02) are available for direct drop shipment. The 50 mL Ansyr II luer-lock syringe, 10 count (NDC 00409-7517-16) are continuing to release as soon as they are available. The Lifeshield syringes are on an intermittent back order and the company is releasing product as it becomes available.
Sep 01
The product is again available.
Sep 01
APP is continuing to allocate as releases occur: 50 mL vial (NDC 63323-0103-51), 100 mL vial (NDC 63323-0103-65) and 200 mL vial (NDC 63323-0103-64). Teva continues to release cisplatin injection 1 mg/mL solution. 50 mL vial (NDC 00703-5747-11) and 100 mL vial (NDC 00703-5748-11) as it becomes available.
Sep 01
Hospira is continuing to release calcium scholride 100 mg/mL Injection 10 mL Ansyr syringes (NDC 00409-1631-10) and 10 mL LifeShield syringes (NDC 00409-4928-34) as they become available.
Sep 01
Bedford anticipates availability by mid-September, 2010.
Aug 31
August 25, 2010 Covidien update.
Aug 25
Sandoz reports weekly releases are occurring for Anectine 20 mg/mL 10 mL vials (NDC 00781-3009-95). Hospira plans release of Quelecin 100 mg/mL, 10 mL Vial (NDC 0409-6970-10) and 20mg/ml 10 mL Vial (NDC 0409-6629-02) by end of August.
Aug 25
Dear Customer Letter for Lantheus.
Aug 20
Hospira has manufacturing delays, Baxter has an increase in demand and Amphastar is currently experiencing manufacturing delays.
Aug 18
APP will clear back-orders and continue to allocate as releases occur. Teva is approximating a release date of August 20th. Cisplatin injection 1 mg/mL solution from Bedford are all on back order with no estimated release date.
Aug 16
Hospira anticipates for NDC 0409-1215-01 (0.4 mg/mL, 1 mL vial) and NDC 0409-1219-01 (0.4 mg/mL, 10 mL vial) they will have releases in August with full recovery by mid September. The NDC 0409-1782-69 (0.4 mg/mL, 1 mL Carpuject) is anticipated for release first quarter of 2011.
Aug 16
Technetium-99m Radiopharmaceutical Product Shortage update.
Aug 10
APP has the 10 mg/mL injection 4 mL vial (NDC 63323-0280-04) available. APP anticipates that the 2 mL vials will be released by mid-September and the 10 ml vials in October, 2010.
Aug 10
APP has haloperidol decanoate available in 50 mg/mL 1 mL vials (NDC 63323-0469-01), 50 mg/mL 5 mL vials (NDC 63323-0469-05), 100 mg/mL 1mL vials (NDC 63323-0471-01), and 100 mg/mL 5 mL vials (NDC 63323-0471-05). The haloperidol decanoate 50 mg/mL 1 mL vials expire 2/2011.
Aug 10
Bedford has mitomycin 5 mg (NDC 55390-0251-01) and 5 mg Novaplus (NDC 55390-0451-01) vials available as well as limited supply of Mitomycin 20 mg (NDC 55390-0252-01) and 20 mg Novaplus (NDC 55390-0452-01) vials. The 40 mg and 40 mg Novaplus vials are planned to be available in early August. Accord has available mitomycin 20 mg vials (NDC 16729-0108-11). The 5 mg vials are anticipated to be available by late August.
Aug 10
Bedford has vecuronium available in 20 mg vials (NDC 55390-0039-10) and 10 mg vials (NDC 55390-0037-10) available.
Drug Shortages